Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) continues to carry a dismal prognosis. The disease is characterized by a uniquely dense fibrotic matrix generated by cancer-associated fibroblasts (CAFs). We have previously demonstrated that fibroblast-driven chronic inflammation suppresses T cell function through a myeloid differentiation primary response protein 88 (MYD88)-dependent mechanism. While extensively studied in myeloid cells, the role of MYD88 signaling in CAFs and its effects on PDAC remain poorly understood. In this study, we identify a MYD88-driven inflammatory CAF population in PDAC using a combination of bulk, single-cell, and spatial transcriptomic studies. Using an innovative collagen gel implantation model, we demonstrate that loss of MYD88 in CAFs enhances T cell infiltration and suppresses tumor growth. Combining MYD88 inhibition with immune checkpoint blockade significantly reduces tumor size and enhances antitumor immune responses, underscoring its potential as a therapeutic target in PDAC.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-09-25
DOI
https://doi.org/10.1016/j.celrep.2025.116347
Citations
1
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma

Khristian E Bauer-Rowe, Byrne Lee, Daniel Delitto, Ovijit Chaudhuri et al.
1 citations
Cell Reports
Epigenetics and DNA Methylation
0.81
article

Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma

Khristian E Bauer-Rowe, Byrne Lee, Daniel Delitto, Ovijit Chaudhuri, Gregory W. Charville, Deshka S. Foster, Heather E. Talbott, Amanda Kirane, Jason L. Guo, Monica M. Dua, Rosyli F. Reveron‐Thornton, Antonio Tomasso, Derrick C. Wan, Amanda Gonçalves, Jeffrey A. Norton, John Lu, Lipika Goyal, George A. Poultsides, Biren Reddy, Ping Xie, Andrea E. Delitto, Maria Korah, Brendan C. Visser, Kenneth W. Yip, Chuner Guo, James Paul Agolia, M R Mohammadi Fallah, Benjamin Pham, Renceh A. B. Flojo, Angela D Tabora
article en
1 citations

Abstract

Pancreatic ductal adenocarcinoma (PDAC) continues to carry a dismal prognosis. The disease is characterized by a uniquely dense fibrotic matrix generated by cancer-associated fibroblasts (CAFs). We have previously demonstrated that fibroblast-driven chronic inflammation suppresses T cell function through a myeloid differentiation primary response protein 88 (MYD88)-dependent mechanism. While extensively studied in myeloid cells, the role of MYD88 signaling in CAFs and its effects on PDAC remain poorly understood. In this study, we identify a MYD88-driven inflammatory CAF population in PDAC using a combination of bulk, single-cell, and spatial transcriptomic studies. Using an innovative collagen gel implantation model, we demonstrate that loss of MYD88 in CAFs enhances T cell infiltration and suppresses tumor growth. Combining MYD88 inhibition with immune checkpoint blockade significantly reduces tumor size and enhances antitumor immune responses, underscoring its potential as a therapeutic target in PDAC.

Cell ReportsVol. 44(10)
Stanford Medicine (US), Stanford University (US)
Openalex Percentile: Top 23%
Epigenetics and DNA Methylation
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.